+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Hyperkalemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767744
  • Report
  • April 2019
  • Region: Global
  • 71 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Ardelyx Inc
  • AstraZeneca Plc
  • CTG Cardiomed Cro Srl
  • Ergomed Plc
  • Medpace Holdings Inc
  • Nestle Health Science SA
  • MORE
The global clinical trial report- “2019 Hyperkalemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hyperkalemia. It presents in-depth analysis of Hyperkalemia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Hyperkalemia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Hyperkalemia clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Hyperkalemia

The research work is prepared through extensive and continuous research on Hyperkalemia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Hyperkalemia patients are identified
  • The report includes panorama of Hyperkalemia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Hyperkalemia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Ardelyx Inc
  • AstraZeneca Plc
  • CTG Cardiomed Cro Srl
  • Ergomed Plc
  • Medpace Holdings Inc
  • Nestle Health Science SA
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Hyperkalemia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Hyperkalemia Clinical Trials by Region
2.2.2 Average Enrollment of Hyperkalemia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Hyperkalemia Treatment, 2019

3. Region wise Hyperkalemia Clinical Trials
3.1 Asia Pacific Hyperkalemia Clinical Trials by Country
3.2 Europe Hyperkalemia Clinical Trials by Country
3.3 North America Hyperkalemia Clinical Trials by Country
3.4 Middle East and Africa Hyperkalemia Clinical Trials by Country
3.5 South and Central America Hyperkalemia Clinical Trials by Country

4. Hyperkalemia Clinical Trial Trends
4.1 Start Year wise Hyperkalemia Clinical Trials
4.2 Phase wise Hyperkalemia Clinical Trials
4.3 Trial Status wise Hyperkalemia Clinical Trials
4.4 Trial Type wise Hyperkalemia Clinical Trials

5. Hyperkalemia Average Enrollment Trends
5.1 Average Enrollment in Hyperkalemia Trials by Year
5.2 Average Enrollment in Hyperkalemia Trials by Phase
5.3 Average Enrollment in Hyperkalemia Trials by Status
5.4 Average Enrollment in Hyperkalemia Trials by Type of Trial

6. Companies Participating in Hyperkalemia Clinical Trials
6.1 Hyperkalemia Trials by Sponsor Type
6.2 Hyperkalemia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Hyperkalemia Trials- Phase 1
7.2 Hyperkalemia Trials- Phase 2
7.3 Hyperkalemia Trials- Phase 3
7.4 Hyperkalemia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Hyperkalemia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Hyperkalemia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Hyperkalemia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Hyperkalemia Clinical Trials and Enrolment
Figure 7: North America - Country wise Hyperkalemia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Hyperkalemia Clinical Trials and Enrolment
Figure 9: Hyperkalemia Clinical Trials by Phase
Figure 10: Hyperkalemia Clinical Trials by Trial Status
Figure 11: Hyperkalemia Clinical Trials by Type
Figure 12: Hyperkalemia Clinical Trials by Sponsor Type
Figure 13: Hyperkalemia Clinical Trials by Leading Sponsors
Figure 14: Hyperkalemia Average Enrollment by Phase
Figure 15: Hyperkalemia Average Enrollment by Trial Status
Figure 16: Hyperkalemia Average Enrollment by Type
Figure 17: Hyperkalemia- Average Enrolment by Type of Sponsors
Figure 18: Hyperkalemia- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Hyperkalemia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Hyperkalemia Clinical Trials and Enrolment
Table 5: Europe - Country wise Hyperkalemia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Hyperkalemia Clinical Trials and Enrolment
Table 7: North America - Country wise Hyperkalemia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Hyperkalemia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Hyperkalemia Average Enrollment by Phase
Table 15: Hyperkalemia Average Enrollment by Trial Status
Table 16: Hyperkalemia Average Enrollment by Type
Table 17: Hyperkalemia- Average Enrolment by Type of Sponsors
Table 18: Hyperkalemia- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Ardelyx Inc
  • AstraZeneca Plc
  • Concordia International Corp
  • CTG Cardiomed Cro Srl
  • Ergomed Plc
  • Medpace Holdings Inc
  • Metabolic Research Institute Inc
  • Nestle Health Science SA
  • Vifor Pharma AG
  • Worldwide Clinical Trials Inc
Note: Product cover images may vary from those shown
Adroll
adroll